However, with the increased focus on obesity and the insulin-resistant state of prediabetes, the search for a long-acting MC4-R-selective peptide agonist for s.c. administration may represent an attractive alternative to a small-molecule compound for the treatment of obesity and improvement of insulin sensitivity. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.